IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KLP Enterprises, LLC

Q2 2017 Holdings

Filed 2017-08-10 | 2 holdings | $17.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics, Inc.COM15117B103$17.0K6,865,006100.0%
ConfidentialCONFIDENTIAL000000000$000.0%